Apigenin

Apigenin is a plant flavonoid proven with biological properties such as anti-inflammatory, antioxidant, and antimicrobial effects. Kuru Bektaşoğlu et al. aimed to examine the possible anti-inflammatory, antioxidant and neuroprotective effects of apigenin in the setting of the mild traumatic brain injury (TBI) model.

Wistar rats were randomly assigned to groups: control (n = 9), TBI (n = 9), TBI + vehicle (n = 8), and TBI + Apigenin (20 and 40 mg/kg, immediately after trauma; n = 6 and n = 7). TBI was performed by dropping a 300 g weight from a height of 1 meter onto the skull under anesthesia. Neurological examination and tail suspension test applied before and 24 hours after trauma, as well as Y-maze and object recognition tests, after that rats were decapitated. In brain tissue, luminol- and lucigenin-enhanced chemiluminescence levels and cytokine ELISA levels were measured. Histological damage was scored. Data was analyzed with one-way ANOVA.

Results: After TBI, luminol (p < 0.001) and lucigenin (p < 0.001) levels increased, and luminol and lucigenin levels decreased with apigenin treatments (p < 0.01-0.001). The tail suspension test score increased with trauma (p < 0.01). According to the pre-traumatic values, the number of entrances to the arms (p < 0.01) in the Y-maze decreased after trauma (p < 0.01). In the object recognition test, discrimination (p < 0.05) and recognition indexes (p < 0.05) decreased with trauma. There was no significant difference among trauma apigenin groups in behavioral tests. Interleukin (IL)-10 levels, one of the anti-inflammatory cytokines, decreased with trauma (p < 0.05), and increased with 20 and 40 mg apigenin treatment (p < 0.001 and p < 0.01, respectively). The histological damage score in cortex were decreased in apigenin 20 mg treatment group significantly (p < 0.05), the decrease observed in apigenin 40 mg group was not significant.

Conclusion: The results of this study revelead that apigenin 20 and 40 mg treatment may have neuroprotective effects in mild TBI via decreasing the the level of luminol and lucigenin and increasing the IL-10 levels. Additionally, apigenin 20 mg treatment ameliorated the trauma-induced cortical tissue damage ¹⁾.

1: Kuru Bektaşoğlu P, Demir D, Koyuncuoğlu T, Yüksel M, Peker Eyüboğlu İ, Karagöz Köroğlu A, Akakın D, Yıldırım A, Çelikoğlu E, Gürer B. Possible anti- inflammatory, antioxidant and neuroprotective effects of apigenin in the setting of mild traumatic brain injury: an investigation. Immunopharmacol Immunotoxicol. 2022 Sep 28:1-28. doi: 10.1080/08923973.2022.2130076. Epub ahead of print. PMID: 36168996.

2: Jia C, Zhao Y, Huang H, Fan K, Xie T, Xie M. Apigenin sensitizes radiotherapy of mouse subcutaneous glioma through attenuations of cell stemness and DNA damage repair by inhibiting NF-κB/HIF-1α-mediated glycolysis. J Nutr Biochem. 2022 Sep;107:109038. doi: 10.1016/j.jnutbio.2022.109038. Epub 2022 May 6. PMID: 35533901.

3: Huang J, Zhou Y, Zhong X, Su F, Xu L. Effects of Vitexin, a Natural Flavonoid Glycoside, on the Proliferation, Invasion, and Apoptosis of Human U251 Glioblastoma Cells. Oxid Med Cell Longev. 2022 Mar 2;2022:3129155. doi: 10.1155/2022/3129155. PMID: 35281458; PMCID: PMC8906934.

4: Wu Q, Yin CH, Li Y, Cai JQ, Yang HY, Huang YY, Zheng YX, Xiong K, Yu HL, Lu AP, Wang KX, Guan DG, Chen YP. Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis. Front Pharmacol. 2021 Dec 6;12:769190. doi: 10.3389/fphar.2021.769190. PMID: 34938184; PMCID: PMC8687625.

5: Zhao Y, Huang H, Jia CH, Fan K, Xie T, Zhu ZY, Xie ML. Apigenin increases radiosensitivity of glioma stem cells by attenuating HIF-1α-mediated glycolysis. Med Oncol. 2021 Sep 23;38(11):131. doi: 10.1007/s12032-021-01586-8. PMID: 34554338.

6: Wang D, Wang Z, Dai X, Zhang L, Li M. Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the <i>PI3K</i>/<i>AKT</i> Pathway. Cancer Biother Radiopharm. 2021 Jan 20. doi: 10.1089/cbr.2020.4283. Epub ahead of print. PMID: 33471569.

7: Yue S, Xue N, Li H, Huang B, Chen Z, Wang X. Hepatoprotective Effect of Apigenin Against Liver Injury via the Non-canonical NF-κB Pathway In Vivo and In Vitro. Inflammation. 2020 Oct;43(5):1634-1648. doi: 10.1007/s10753-020-01238-5. PMID: 32458347.

8: Chen P, Huo X, Liu W, Li K, Sun Z, Tian J. Apigenin exhibits anti- inflammatory effects in LPS-stimulated BV2 microglia through activating GSK3β/Nrf2 signaling pathway. Immunopharmacol Immunotoxicol. 2020 Feb;42(1):9-16. doi: 10.1080/08923973.2019.1688345. Epub 2019 Nov 25. PMID: 31760890.

9: Xie T, Wang JR, Dai CG, Fu XA, Dong J, Huang Q. Vitexin, an inhibitor of hypoxia-inducible factor-1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma. Clin Transl Oncol. 2020 Jul;22(7):1086-1093. doi: 10.1007/s12094-019-02234-4. Epub 2019 Nov 1. PMID: 31677055.

10: Lin TJ, Yin SY, Hsiao PW, Yang NS, Wang IJ. Transcriptomic analysis reveals a controlling mechanism for NLRP3 and IL-17A in dextran sulfate sodium (DSS)-induced colitis. Sci Rep. 2018 Oct 8;8(1):14927. doi: 10.1038/s41598-018-33204-5. PMID: 30297787; PMCID: PMC6175949.

11: Choi WH, Jang YJ, Son HJ, Ahn J, Jung CH, Ha TY. Apigenin inhibits sciatic nerve denervation-induced muscle atrophy. Muscle Nerve. 2018 Aug;58(2):314-318. doi: 10.1002/mus.26133. Epub 2018 Apr 17. PMID: 29572868.

12: Zhang G, Li D, Chen H, Zhang J, Jin X. Vitexin induces G2/M‑phase arrest and apoptosis via Akt/mTOR signaling pathway in human glioblastoma cells. Mol Med Rep. 2018 Mar;17(3):4599-4604. doi: 10.3892/mmr.2018.8394. Epub 2018 Jan 8. PMID: 29328424.

13: Wan Y, Fei X, Wang Z, Jiang D, Chen H, Wang M, Zhou S. miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway. Tumour Biol. 2017 Apr;39(4):1010428317695526. doi: 10.1177/1010428317695526. PMID: 28381178.

14: Li Q, Chen Y, Zhang X, Zuo S, Ge H, Chen Y, Liu X, Zhang JH, Ruan H, Feng H. Scutellarin attenuates vasospasm through the Erk5-KLF2-eNOS pathway after subarachnoid hemorrhage in rats. J Clin Neurosci. 2016 Dec;34:264-270. doi: 10.1016/j.jocn.2016.09.028. Epub 2016 Oct 11. PMID: 27742373.

15: Chen XJ, Wu MY, Li DH, You J. Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP‑9. Mol Med Rep. 2016 Sep;14(3):2352-8. doi: 10.3892/mmr.2016.5460. Epub 2016 Jun 30. PMID: 27430517.

16: Dai B, Hu Z, Li H, Yan C, Zhang L. Simultaneous determination of six flavonoids from Paulownia tomentosa flower extract in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 26;978-979:54-61. doi: 10.1016/j.jchromb.2014.11.021. Epub 2014 Dec 3. PMID: 25531870; PMCID: PMC7105214.

17: Wang Y, Xu YS, Yin LH, Xu LN, Peng JY, Zhou H, Kang W. Synergistic anti- glioma effect of Hydroxygenkwanin and Apigenin in vitro. Chem Biol Interact. 2013 Nov 25;206(2):346-55. doi: 10.1016/j.cbi.2013.10.009. Epub 2013 Oct 19. PMID: 24144774.

18: Parajuli P, Joshee N, Rimando AM, Mittal S, Yadav AK. In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids. Planta Med. 2009 Jan;75(1):41-8. doi: 10.1055/s-0028-1088364. Epub 2008 Nov 24. PMID: 19031366.